a a a a a
a in the Care of Older Adults, 3rd Edition
a a a a a a a a
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
a a a a a a a a
,Answers at the end of the Chapter
a a a a a a
Chapter 1: Changes with Aging a a a a
Multiple Choice a
Identify the choice that best completes the statement or answers the question.
a a a a a a a a a a a
1. The major impact of the physiological changes that occur with aging is:
a a a a a a a a a a a
A. Reduced physiological reserve a a
B. Reduced homeostatic mechanismsa a
C. Impaired immunological response
a a
D. All of the above
a a a
2. The strongest evidence regarding normal physiological aging is available through:
a a a a a a a a a
,A. Randomized controlled clinical trials a a a
B. Cross-sectional studies a
C. Longitudinal studies a
D. Case control studies
a a
3. All of the following statements are true about laboratory
a a a a a a a a
values in older adultsexcept:
a a a a
A. Reference ranges are preferable
a a a
B. Abnormal findings are often due to physiological aging
a a a a a a a
C. Normal ranges may not be applicable for older adults
a a a a a a a a
D. Reference values are not necessarily acceptable values
a a a a a a
4. Biochemical individuality is best described as: a a a a a
A. Each individual’s variation is often much greater than that of a larger group
a a a a a a a a a a a a
B. The unique biochemical profile of a selected population
a a a a a a a
C. The truly “normal” individual—falling within average range
a a a a a a
D. Each individual’s variation is often much smaller than that of a larger group
a a a a a a a a a a a a
5. Polypharmacy ois obest odescribed oas otaking: a a a a a
A. More othan onine omedications oper oday
a a a a a
B. Moreothan ofive omedications oper oday
a a a a
, C. Even oa osingle omedication oif othere ois onot oa oclear oindication ofor oits ouse
a a a a a a a a a a a a a
D. When oa odrug ois ogiven oto otreat othe oside oeffect oof oanother odrug
a a a a a a a a a a a a
ao ao a o 6. o Pharmacokinetic ochanges owithoagingois oreflective oof:
a a a a a a a
A. What othe odrug odoes oto othe obody
a a a a a a
B. What othe obody odoes oto othe odrug
a a a a a a
C. The oeffect oat othe osite oof oaction oand othe otime oand ointensity oof othe odrug
a a a a a a a a a a a a a a
D. The oside oeffects ocommonly oassociated owith othe odrug
a a a a a a a
a o ao a o 7. o All othe ofollowing ostatements oare ofalse oabout odrug oabsorption oexcept:
a a a a a a a a a a a
A. Antacids oincrease othe obioavailability oof odigitalis
a a a a a
B. Gastric oacidity odecreases owith oage
a a a a
C. Anticholinergics oincreaseocolonic omotility a a a
D. Underlyingochronic odisease ohas olittle oimpact oon odrug oabsorption
a a a a a a a a
a 8. o Alloof othe ofollowing ostatements oare otrue oabout odrug odistribution oin othe
o ao a o a a a a a a a a a a a a a
elderly oexcept:
a a
A. Drugs odistributed oin owater ohave olower oconcentration
a a a a a a
B. Drugs odistributed oin ofat ohave oless ointense, omore oprolonged oeffect
a a a a a a a a a
C. Drugs ohighly oprotein obound ohave ogreater opotential oto ocauseoan oadverse odrug oreaction
a a a a a a a a a a a